Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer

NCT04791384 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Study was terminated due to delayed recruitment.

Conditions

Breast Cancer

Interventions

DRUG: Abemaciclib
DRUG: Elacestrant

Sponsor

Criterium, Inc.